Citation Impact
Citing Papers
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
2001
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation
1999
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Maintenance treatment of Crohn's disease
2003
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Probiotics—compensation for lactase insufficiency
2001
Inflammation and cancer
2002 StandoutNature
Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens
2004
Correlation between endoscopic severity and the clinical activity index in ulcerative colitis
1998
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
2010
Bowel Disorders
2016 Standout
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
2015
Human Genetics Shape the Gut Microbiome
2014 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
2000
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease
2015
Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas
1993
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
2001
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Crohn's disease
2012 Standout
Starch malabsorption and breath gas excretion in healthy humans consuming low- and high-starch diets
1988
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn??s disease
1997
Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons
1997
Effect of resistant starch on breath-hydrogen and methane excretion in healthy volunteers
1994
An in vitro study of short-chain fatty acid concentrations, production and absorption in pig (Sus scrofa) colon
1992
Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: Report of 100 consecutive cases
2004 Standout
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Ulcerative Colitis and Colorectal Cancer
1990 Standout
Predicting Endoscopic Disease Activity in Crohnʼs Disease
2015
Super-efficient starch absorption
1987
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
2004 Standout
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
1995
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease
2018
Tc-99m-PEG-Liposomes for the Evaluation of Colitis in Crohn's Disease
2000
Irritable bowel syndrome
2016 Standout
Digestion and physiological properties of resistant starch in the human large bowel
1996
Predicting Endoscopic Crohnʼs Disease Activity Before and After Induction Therapy in Children
2015
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI
2000
Inflammation and Colon Cancer
2010 Standout
Fulminant Hepatitis in A Tropical Population: Clinical Course, Cause, and Early Predictors of Outcome
1996
Clinical Relevance of Serum Interleukin-6 in Crohn's Disease: Single Point Measurements, Therapy Monitoring, and Prediction of Clinical Relapse
1999
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride
2003
The effect of resistant starch on colon function in humans
1990
Treatment of Somatoform Disorders With St. Johnʼs Wort: A Randomized, Double-Blind and Placebo-Controlled Trial
2004
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
1995 Standout
Intestinal Permeability Test As A Predictor of Clinical Course in Crohn's Disease
1999
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation
1994
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
2013
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
2008
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn’s Disease
2019
Endoscopy in inflammatory bowel disease
2002
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Absorption of Wheat Starch in Patients Resected for Left-Sided Colonic Cancer
1992
New Concepts in Intestinal Imaging for Inflammatory Bowel Diseases
2011
Predictors of severe Crohn's disease
2008
Ulcerative colitis
2016 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Gut flora in health and disease
2003 Standout
Acetaminophen‐induced acute liver failure
2005 Standout
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study
2007 Standout
In Vitro Fermentation of High‐Amylose Cornstarch by a Mixed Population of Colonic Bacteria
1997
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
2013
Inflammation and the development of pancreatic cancer
2002
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Inflammatory Bowel Disease
1996
Fecal Short-Chain Fatty Acids in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: In Vitro Studies of Carbohydrate Fermentation
1996
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
2015
Inhibition of secondary bile acid formation in the large intestine by lactulose in healthy subjects of two different age groups
1988
Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease
1998
IgG4-related disease
2014 Standout
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
2013
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
2015
Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
1999
Colonic Fermentation of Ispaghula, Wheat Bran, Glucose, and Albumin to Short‐Chain Fatty Acids and Ammonia Evaluated in Vitro in 50 Subjects
1992
Taxonomic, Phylogenetic, and Ecological Diversity of Methanogenic Archaea
2000
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Effect of Starch Malabsorption on Colonic Function and Metabolism in Humans
1988
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Comparison of fermentation reactions in different regions of the human colon
1992
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
2006
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Administration of Transgalacto-Oligosaccharides Increases Fecal Bifidobacteria and Modifies Colonic Fermentation Metabolism in Healthy Humans
1997
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease
1996
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
2004
Prediction of Poor Outcome in Patients with Acute Liver Failure—Systematic Review of Prediction Models
2012
The pros, cons, and many unknowns of probiotics
2019 Standout
The limitations of corticosteroid therapy in Crohn’s disease
2001
Contribution of the digestive tract microflora to amylomaize starch degradation in the rat
1992
Endoscopic evaluation of patients with inflammatory bowel disease
2008
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
2015
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease
2009
Irritable Bowel Syndrome
2015 Standout
Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans
1990
Review article: the natural history of postoperative C rohn's disease recurrence
2012
Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity
2018
Intestinal methane production in obese individuals is associated with a higher body mass index.
2012
Maintenance Therapy in Crohn's Disease
2000
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener
1987
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Colon Cancer, Dysplasia, and Surveillance in Patients with Ulcerative Colitis
1987
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
2013
Occurrence, Classification, and Biological Function of Hydrogenases: An Overview
2007 Standout
Course of Crohn's disease after allogeneic marrow transplantation
1998
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Short-Chain Fatty Acids and the Irritable Bowel Syndrome: The Effect of Wheat Bran
1987
Inflammatory Bowel Disease
2010 Standout
Correlation between endoscopic severity and the clinical activity index in ulcerative colitis
1998
Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab
2019
Comparative Study of Bacterial Groups within the Human Cecal and Fecal Microbiota
2001
Comparison of fermentation reactions in different regions of the human colon
1992
Growth Factors and Cancer
1991 StandoutScience
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002 Standout
Enteral nutritional therapy for induction of remission in Crohn's disease
2007
Traditional corticosteroids for induction of remission in Crohn's disease
2008
Effects of Lactulose and Lactitol on Colonic Microflora and Enzymatic Activity
1997
Correlation between Faecal Excretion of Indium-111-Labelled Granulocytes and Calprotectin, a Granulocyte Marker Protein, in Patients with Inflammatory Bowel Disease
1999
Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome.
2014
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria
2000
Works of C Florent being referenced
Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates.
1990
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
1994
Diagnostic Value of Endoscopic Capsule in Patients with Obscure Digestive Bleeding: Blinded Comparison with Video Push-Enteroscopy
2003
Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
1992
Emergency liver transplantation for acute liver failure
1993
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study
1993
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs disease
1996
Treatment of Crohn's disease by lymphocyte apheresis: A randomized controlled trial
1994
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
1995
Dysplasia and cancer in ulcerative colitis.
1989
Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study).
1985
[Sulpiride: study of 669 patient presenting with pain of psychological origin].
2001
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
1993
Idiopathic pancreatitis associated with inflammatory bowel disease
1985
[Methanogenesis in man].
1987
Colonic metabolism of wheat starch in healthy humans
1986